Choongwae's Curoxin, new quinolone anti-bacterial drug, to launch soon.

Published: 2001-12-17 06:57:00

Updated: 2001-12-17 06:57:00

Choongwe (President: Lee Kyung-ha) announced on Dec. 13 that they may get the health registration approval for Curoxin (Balofloxacin), a new quinolone antibacterial agent from the KFDA on Dec. 17 through the Central Pharmaceutical Affairs Review Council after successful completion of the clinical phase III studies.

Curoxin will be the 4th new drug in Korea after SK's Sunpla (an anti-cancer d...

Fees

- Email service daily and homepage access.

$300 per month.
5 Email holders per each company.
Anual contract base.